Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gilles Edan

Showing results (31-40 of 149) with videos related to

Pageof 15
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|October 3, 2002
Choreic syndrome due to Hashimoto's encephalopathyGregory Taurin, Véronique Golfier, Jean-François Pinel, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 17, 2019
Decreasing impact of late relapses on disability worsening in secondary progressive multiple sclerosisKevin Ahrweiller, Chloé Rousseau, Emmanuelle Le Page, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|February 6, 2008
Determination of interferon beta neutralizing antibodies in multiple sclerosis: improvement of clinical sensitivity of a cytopathic effect assayCatherine Massart, Jacqueline Gibassier, Jérôme de Seze, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 6, 2021
Cumulative effects of therapies on disability in relapsing multiple sclerosisFabien Rollot, Romain Casey, Emmanuelle Leray, et al.
Journal of Neurology|June 9, 2019
Joint assessment of brain and spinal cord motor tract damage in patients with early RRMS: predominant impact of spinal cord lesions on motor functionRaphaël Chouteau, Benoit Combès, Elise Bannier, et al.
The Lancet. Neurology|January 22, 2008
Intense immunosuppression in patients with rapidly worsening multiple sclerosis: treatment guidelines for the clinicianAaron Boster, Gilles Edan, Elliott Frohman, et al.
Journal of Neurology|September 19, 2022
Discontinuation of second- versus first-line disease-modifying treatment in middle-aged patients with multiple sclerosisMaëlle Chappuis, Chloé Rousseau, Emma Bajeux, et al.
European Journal of Neurology|June 11, 2024
Scoping review of clinical decision support systems for multiple sclerosis management: Leveraging information technology and massive health dataStanislas Demuth, Chadia Ed-Driouch, Cédric Dumas, et al.
Multiple Sclerosis and Related Disorders|March 31, 2023
Switching from natalizumab administration at the day hospital to administration at home. A 1 year prospective study of patient experience and quality of life in 30 consecutive patients with multiple sclerosis (TYSAD-35)Simon Lamy, David Veillard, Hélène Doyen, et al.
Journal of Neurology|March 22, 2005
Only physical aspects of quality of life are significantly improved by bilateral subthalamic stimulation in Parkinson's diseaseSophie Drapier, Sylvie Raoul, Dominique Drapier, et al.
Pageof 15

Showing results (31-40 of 149) with videos related to

Sort By:
Pageof 15
Movement Disorders : Official Journal of the Movement Disorder Society|October 3, 2002
Choreic syndrome due to Hashimoto's encephalopathyGregory Taurin, Véronique Golfier, Jean-François Pinel, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 17, 2019
Decreasing impact of late relapses on disability worsening in secondary progressive multiple sclerosisKevin Ahrweiller, Chloé Rousseau, Emmanuelle Le Page, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|February 6, 2008
Determination of interferon beta neutralizing antibodies in multiple sclerosis: improvement of clinical sensitivity of a cytopathic effect assayCatherine Massart, Jacqueline Gibassier, Jérôme de Seze, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 6, 2021
Cumulative effects of therapies on disability in relapsing multiple sclerosisFabien Rollot, Romain Casey, Emmanuelle Leray, et al.
Journal of Neurology|June 9, 2019
Joint assessment of brain and spinal cord motor tract damage in patients with early RRMS: predominant impact of spinal cord lesions on motor functionRaphaël Chouteau, Benoit Combès, Elise Bannier, et al.
The Lancet. Neurology|January 22, 2008
Intense immunosuppression in patients with rapidly worsening multiple sclerosis: treatment guidelines for the clinicianAaron Boster, Gilles Edan, Elliott Frohman, et al.
Journal of Neurology|September 19, 2022
Discontinuation of second- versus first-line disease-modifying treatment in middle-aged patients with multiple sclerosisMaëlle Chappuis, Chloé Rousseau, Emma Bajeux, et al.
European Journal of Neurology|June 11, 2024
Scoping review of clinical decision support systems for multiple sclerosis management: Leveraging information technology and massive health dataStanislas Demuth, Chadia Ed-Driouch, Cédric Dumas, et al.
Multiple Sclerosis and Related Disorders|March 31, 2023
Switching from natalizumab administration at the day hospital to administration at home. A 1 year prospective study of patient experience and quality of life in 30 consecutive patients with multiple sclerosis (TYSAD-35)Simon Lamy, David Veillard, Hélène Doyen, et al.
Journal of Neurology|March 22, 2005
Only physical aspects of quality of life are significantly improved by bilateral subthalamic stimulation in Parkinson's diseaseSophie Drapier, Sylvie Raoul, Dominique Drapier, et al.
Pageof 15